(-)-epigallocatechin-3-gallate (EGCG) increases OPG/RANKL expression in osteoclast feeder cell, ST2

被引:0
|
作者
Huang, P. [1 ]
Chen, C. [1 ]
Kang, L. [2 ]
Hung, S. [1 ]
Wang, G. [1 ]
Chang, J. [1 ]
机构
[1] Kaohsiung Med Univ, Dept Orthoped, Kaohsiung, Taiwan
[2] Natl Cheng Kung Univ, Dept Obstet & Gynecol, Tainan 70101, Taiwan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S99 / S100
页数:2
相关论文
共 50 条
  • [21] Epigallocatechin-3-Gallate (EGCG) Inhibits Cell Proliferation and Migratory Behaviour of Triple Negative Breast Cancer Cells
    Braicu, Cornelia
    Gherman, Claudia D.
    Irimie, Alexandru
    Berindan-Neagoe, Ioana
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2013, 13 (01) : 632 - 637
  • [22] Epigallocatechin-3-gallate Delivered in Nanoparticles Increases Cytotoxicity in Three Breast Carcinoma Cell Lines
    Farabegoli, Fulvia
    Granja, Andreia
    Magalhaes, Joana
    Purgato, Stefania
    Voltattorni, Manuela
    Pinheiro, Marina
    ACS OMEGA, 2022, 7 (46): : 41872 - 41881
  • [23] Green tea epigallocatechin-3-gallate (EGCG) increases the formation of mineralized bone nodules by human osteoblast-like cells
    Vali, B
    Rao, LG
    El-Sohemy, A
    FASEB JOURNAL, 2004, 18 (05): : A919 - A919
  • [24] (-)- Epigallocatechin-3-Gallate (EGCG) Increases the Viability of Serum-Starved A549 Cells Through Its Effect on Akt
    Kim, Myung Jin
    Kim, Hyung Il
    Chung, Jin
    Jeong, Tae Sung
    Park, Hae Ryoun
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2009, 37 (04): : 723 - 734
  • [25] Reduction in promotor methylation utilizing EGCG (Epigallocatechin-3-gallate) restores RXRα expression in human colon cancer cells
    Morris, Jay
    Moseley, Vondina R.
    Cabang, April B.
    Coleman, Katie
    Wei, Wei
    Garrett-Mayer, Elizabeth
    Wargovich, Michael J.
    ONCOTARGET, 2016, 7 (23) : 35313 - 35326
  • [26] Oxidation derivative of (-)-epigallocatechin-3-gallate (EGCG) inhibits RANKL-induced osteoclastogenesis by suppressing RANK signaling pathways in RAW 264.7 cells
    Xu, Huanhuan
    Liu, Titi
    Li, Jin
    Xu, Jing
    Chen, Fei
    Hu, Lihong
    Zhang, Banglei
    Zi, Chengting
    Wang, Xuanjun
    Sheng, Jun
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 118
  • [27] The involvement of Nrf2 in the protective effects of (-)-Epigallocatechin-3-gallate (EGCG) on NaAsO2-induced hepatotoxicity
    Han, Xiao-Dong
    Zhang, Yan-Yan
    Wang, Ke-Lei
    Huang, Yong-Pan
    Yang, Zhong-Bao
    Liu, Zhi
    ONCOTARGET, 2017, 8 (39) : 65302 - 65312
  • [28] EPIGALLOCATECHIN-3-GALLATE (EGCG)IMPROVES CELL VIABILITY FOLLOWING HYPEROXIA EXPOSURE IN CULTURED RESPIRATORY EPITHELIAL CELLS.
    Wheeler, Derek S.
    Lahni, Patrick M.
    Wong, Hector R.
    CRITICAL CARE MEDICINE, 2008, 36 (12) : A4 - A4
  • [29] Effect of epigallocatechin-3-gallate (EGCG) and related polyphenols on the viability of cancerous and non-cancerous murine cell lines
    Henry, Carolyne
    Hagan, Thomas
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [30] Effects of epigallocatechin-3-gallate (EGCG) on cell growth and apoptosis of prostate cancer lines and its interactions with dihydrotestosterone (DHT)
    Thomas, F.
    Patel, S.
    Holly, J.
    Persad, R.
    Perks, C. M.
    BJU INTERNATIONAL, 2007, 100 : 41 - 41